Moon J. Noh, Ph.D.
Chief Executive Officer
- TG-C US FDA 임상1, 2상 완료
- 서울대 미생물학 학사 ('89) / 카이스트 생명과학 박사 ('95)
전승호
Chief Executive Officer
- 대웅제약 대표이사 사장 (’18~’24)
- 한국과학기술지주 이사 (’23~현재)
- 미래의학연구재단 고문 및 이사 (’21~현재)
- 서울대학교 제약학 학사 (1999) / 서울대학교 대학원 제약학 석사 (2001)
- 알토대학교 경제대학원 MBA (2013)
- 연세대학교 대학원 약학 박사 (2023)
이규호
Inside Director
- Kolon TissueGene, Inc., Inside Director ('26 ~ 현재)
- Kolon Group, 부회장 ('24 ~ 현재)
- Kolon Corporation, CEO ('24 ~ 현재)
- Kolon Corporation, Chief Strategy Officer (’20 ~ ’23)
- BS in Hotel Administration, Cornell University
김정인
Chief Financial Officer
- Kolon TissueGene, Inc.('21~현재)
- ㈜ 코오롱 경영관리실('13~'21)
- 국민대학교 수학과 학사('02)
Jan Van Acker
Independent Director
- Strategic Advisor in healthcare and biopharmaceuticals (’24 ~ 현재)
- Strategic Advisor - ARC innovation hub of Sheba Medical Center (‘24 ~ 현재)
- Merck & Co., Inc. Senior Vice President, Global Human Health, MSD Switzerland (‘15 ~ ’23)
- Universiteit Gent, M.S. Degree in Mechanical Engineering (‘89)
- MIT, MS degree in Management, MS degree in Technology and Policy (‘91)
Robert Ang
Independent Director
- Alliance for Regenerative Medicine(비영리법인) Vice-Chair & Board (’22 ~ 현재)
- Enara Bio Board Member / Chair (’21 ~ 현재)
- Vor Bio(NASDAQ), President & CEO (’19 ~ ‘25)
- Bachelor of Medicine and Bachelor of Surgery (Medical Degree), UNIVERSITY OF WESTERN AUSTRALIA SCHOOL OF MEDICINE(‘97)
- MBA Finance and Entrepreneurship with Honors, COLUMBIA GRADUATE SCHOOL OF BUSINESS(‘05)
Young J. Kim, Ph.D.
Statutory Auditor
- Kolon TissueGene, Inc. 상근감사 ('17~현재)
- Young Enterprise System, Inc. ('99~'16)
- TRW System & Information Technology Group ('94~'99)
- Martin Marietta Corp ('93~'94)
- ITC Corporation ('91~'93)
- Doctorate in Engineering Management at George Washington University